ANDA Challenges To Formulation Patents May Get Easier After KSR Ruling
Executive Summary
The pharmaceutical industry could have a tougher time protecting certain drug patents - particularly those in ANDA litigation - following a U.S. Supreme Court decision that expands the situations under which an invention can be considered obvious
You may also be interested in...
Patent News Round Up: Supreme Court Asked To Review Plavix Patent; New Director May Scrap PTO Rules; Patenting Of Natural Process Debated
Apotex really wants to get a generic version of Plavix (clopidogrel) on the market before the patent on the drug expires in 2011. Defeated in its efforts to get the patent ruled invalid, the company has asked the Supreme Court to take up the case
Patent News Round Up: Supreme Court Asked To Review Plavix Patent; New Director May Scrap PTO Rules; Patenting Of Natural Process Debated
Apotex really wants to get a generic version of Plavix (clopidogrel) on the market before the patent on the drug expires in 2011. Defeated in its efforts to get the patent ruled invalid, the company has asked the Supreme Court to take up the case
Biotech Inventions May Be More Easily Deemed Obvious Under Court Ruling
An appeals court ruling that limits the patenting of DNA sequences could have negative repercussions for the industry